secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rapport Therapeutics, Inc. (RAPP)
CIK:        0002012593
Form:       8-K
Filed at:   2025-09-08T23:59:59+00:00
Accession:  0001193125-25-198322
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rapport Therapeutics terminates ATM equity offering program; no shares sold
---------------------------------------------------------------------------

- Effective Sept 8, 2025, terminated the ATM prospectus under the S-3 registration statement.
- Sales Agreement with Leerink and Cantor remains in effect but no sales without new filing.
- No shares of common stock were issued or sold under the program as of termination date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2012593/000119312525198322/0001193125-25-198322-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2012593/000119312525198322/d56083d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-198322

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer